AML1-ETO-positive acute myeloid leukemia presents different phenotype in pediatric and adult patients
Guopan Yu(Nanfang Hospital), Dan Xu(Wuhan University), Sanfang Tu(Zhujiang Hospital), Qifa Liu(University of Science and Technology of China), Danian Nie(Sun Yat-sen University), Xuejie Jiang(Nanfang Hospital), Changxin Yin(Nanfang Hospital), Jiale Qiu(Southern Medical University), Hui Zhang(Capital Medical University), Yiqing Li(Sun Yat-sen University), Xiaolan Xu(Tongji Hospital), Dan Fang(Nanfang Hospital), Shuangfeng Xie(Sun Yat-sen University), Jiaheng Zhou(Chinese Academy of Sciences), Zhao Yin(Nanfang Hospital), Ying Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhenqian Huang(First Affiliated Hospital of Guangzhou Medical University), Jinchang Zhou(Southern Medical University)
Cited by 0
Related Papers
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study
|The Lancet Respiratory Medicine|2022|609
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
|Frontiers in Immunology|2017|209